CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients
出版年份 2014 全文链接
标题
CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients
作者
关键词
Sulphonylureas, Type 2 diabetes, Hypoglycemia episodes, <em class=EmphasisTypeItalic >CYP2C9</em>, <em class=EmphasisTypeItalic >KCNJ11</em>, <em class=EmphasisTypeItalic >ABCC8</em>, Polymorphism
出版物
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 70, Issue 4, Pages 421-428
出版商
Springer Nature
发表日期
2014-01-17
DOI
10.1007/s00228-014-1641-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
- (2013) E. R. Seaquist et al. DIABETES CARE
- Treating older people
- (2013) Ken Woodhouse EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Meta-analysis of association of common variants in the KCNJ11-ABCC8 region with type 2 diabetes
- (2013) L.J. Qin et al. GENETICS AND MOLECULAR RESEARCH
- Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes: Real-world diabetes therapy in a clinical trial cohort
- (2012) J. D. Best et al. DIABETES CARE
- Association of KCNJ11 E23K gene polymorphism with hypoglycemia in sulfonylurea-treated Type 2 diabetic patients
- (2012) Georgia Ragia et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Medication prescribing in frail older people
- (2012) Ruth E. Hubbard et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2C metabolism of oral antidiabetic drugs - impact on pharmacokinetics, drug interactions and pharmacogenetic aspects
- (2012) Andreas Holstein et al. Expert Opinion on Drug Metabolism & Toxicology
- The Effect of KCNJ11 Polymorphism on the Risk of Type 2 Diabetes: A Global Meta-Analysis Based on 49 Case-Control Studies
- (2011) Bo Gong et al. DNA AND CELL BIOLOGY
- Population pharmacokinetic analysis of glimepiride with CYP2C9 genetic polymorphism in healthy Korean subjects
- (2011) Hee-Doo Yoo et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting
- (2011) Osman Gökalp et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia
- (2011) Andreas Holstein et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients
- (2011) A. Surendiran et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- KCNJ11 gene E23K variant and therapeutic response to sulfonylureas
- (2011) Martin Javorsky et al. European Journal of Internal Medicine
- Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients
- (2010) Andreas Holstein et al. Expert Opinion On Drug Safety
- Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics and pharmacodynamics of gliclazide in healthy Chinese Han volunteers
- (2010) H. Shao et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- ABCC8polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas
- (2010) Ryosuke Sato et al. PHARMACOGENOMICS
- Effect ofCYP2C9polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus
- (2010) Jesse J Swen et al. PHARMACOGENOMICS
- Loss-of-Function CYP2C9 Variants Improve Therapeutic Response to Sulfonylureas in Type 2 Diabetes: A Go-DARTS Study
- (2009) K Zhou et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects
- (2009) Bo Tan et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The E23K Variant ofKCNJ11and the Risk for Severe Sulfonylurea-induced Hypoglycemia in Patients with Type 2 Diabetes
- (2009) A. Holstein et al. HORMONE AND METABOLIC RESEARCH
- Presence ofCYP2C9*3allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas
- (2009) Georgia Ragia et al. PHARMACOGENOMICS
- Ser1369Ala Variant in Sulfonylurea Receptor Gene ABCC8 Is Associated With Antidiabetic Efficacy of Gliclazide in Chinese Type 2 Diabetic Patients
- (2008) Y. Feng et al. DIABETES CARE
- Glycaemic control and adverse events in patients with type 2 diabetes treated with metformin + sulphonylurea: a meta-analysis
- (2008) J. Belsey et al. DIABETES OBESITY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started